The frequent UCP2-866G>A polymorphism protects against insulin resistance and is associated with obesity: A study of obesity and related metabolic traits among 17 636 Danes

International Journal of Obesity

Volumn 37, Issue 2, 2013, Pages 175-181

  Andersen, G ^a   Dalgaard, L T ^b   Justesen, J M ^c   Anthonsen, S ^a,b   Nielsen, T ^c   Thorner L W ^a   Witte, D ^d   Jorgensen T ^e,f   Clausen, J O ^d   Lauritzen, T ^g   Holmkvist, J ^a   Hansen, T ^a,c,h   Pedersen, O ^a,c,f,i  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b ROSKILDE UNIVERSITY   (Denmark)

^c Capital Region   (Denmark)

^d STENO DIABETES CENTER   (Denmark)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

^h UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

ⁱ AARHUS UNIVERSITY   (Denmark)

Author keywords

866G A polymorphism; diabetes; genetics; insulin sensitivity; rs659366; uncoupling protein 2

Indexed keywords

GLUCOSE; INSULIN; REACTIVE OXYGEN METABOLITE; UNCOUPLING PROTEIN 2;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME REGULATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; QUANTITATIVE TRAIT;

ALLELES; ANIMALS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RESISTANCE; ION CHANNELS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84873712711     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.22     Document Type: Article

References (60)

1. Dalgaard LT, Pedersen O. Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia 2001; 44: 946-965.
2. Dalgaard LT. Genetic variance in uncoupling protein 2 in relation to obesity, type diabetes, and related metabolic traits: focus on the functional-866g4a promoter variant (rs659366). J Obes 2011; 2011: 340241.
3. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997; 15: 269-272.
4. Gimeno RE, Dembski M, Weng X, Deng N, Shyjan AW, Gimeno CJ et al. Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes 1997; 46: 900-906.
5. Chan CB, MacDonald PE, Saleh MC, Johns DC, Marban E, Wheeler MB. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 1999; 48: 1482-1486.
6. Kashemsant N, Chan CB. Impact of uncoupling protein-2 overexpression on proinsulin processing. J Mol Endocrinol 2006; 37: 517-526.
7. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001; 105: 745-755.
8. Krauss S, Zhang CY, Scorrano L, Dalgaard LT, St Pierre J, Grey ST et al. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 2003; 112: 1831-1842.
9. Pi J, Bai Y, Daniel KW, Liu D, Lyght O, Edelstein D et al. Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic beta-cell function. Endocrinology 2009; 150: 3040-3048.
10. Joseph JW, Koshkin V, Zhang CY, Wang J, Lowell BB, Chan CB et al. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 2002; 51: 3211-3219.
11. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 2000; 26: 435-439.
12. de Souza CT, Araujo EP, Stoppiglia LF, Pauli JR, Ropelle E, Rocco SA et al. Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and action. FASEB J 2007; 21: 1153-1163.
13. Gonzalez-Barroso MM, Giurgea I, Bouillaud F, Anedda A, Bellanne-Chantelot C, Hubert L et al. Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion. PLoS One 2008; 3: e3850.
14. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 2001; 28: 178-183.
15. Dalgaard LT, Andersen G, Larsen LH, Sorensen TI, Andersen T, Drivsholm T et al. Mutational analysis of the UCP2 core promoter and relationships of variants with obesity. Obes Res 2003; 11: 1420-1427.
16. Wang H, Chu WS, Lu T, Hasstedt SJ, Kern PA, Elbein SC. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am J Physiol Endocrinol Metab 2004; 286: E1-E7.
17. Sasahara M, Nishi M, Kawashima H, Ueda K, Sakagashira S, Furuta H et al. Uncoupling protein 2 promoter polymorphism-866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients. Diabetes 2004; 53: 482-485.
18. Mancini FP, Sabatino L, Colantuoni V, Pasanisi F, Finelli C, Contaldo F et al. Variants of uncoupling protein-2 gene and obesity: interaction with peroxisome proliferator-activated receptorgamma2. Clin Endocrinol 2003; 59: 817-822.
19. Sesti G, Cardellini M, Marini MA, Frontoni S, D'Adamo M, Del Guerra S et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 2003; 52: 1280-1283.
20. D'Adamo M, Perego L, Cardellini M, Marini MA, Frontoni S, Andreozzi F et al. The-866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes 2004; 53: 1905-1910.
21. Ji Q, Ikegami H, Fujisawa T, Kawabata Y, Ono M, Nishino M et al. A common polymorphism of uncoupling protein 2 gene is associated with hypertension. J Hypertens 2004; 22: 97-102.
22. Le Fur S, Le Stunff C, Dos Santos C, Bougneres P. The common-866 G/A polymorphism in the promoter of uncoupling protein 2 is associated with increased carbohydrate and decreased lipid oxidation in juvenile obesity. Diabetes 2004; 53: 235-239.
23. Bulotta A, Ludovico O, Coco A, Di PR, Quattrone A, Carella M et al. The common-866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy. J Clin Endocrinol Metab 2005; 90: 1176-1180.
24. Kovacs P, Ma L, Hanson RL, Franks P, Stumvoll M, Bogardus C et al. Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians. Diabetologia 2005; 48: 2292-2295.
25. Cha MH, Kim IC, Kim KS, Kang BK, Choi SM, Yoon Y. Association of UCP2 and UCP3 gene polymorphisms with serum high-density lipoprotein cholesterol among Korean women. Metabolism 2007; 56: 806-813.
26. Gable DR, Stephens JW, Dhamrait SS, Hawe E, Humphries SE. European differences in the association between the UCP2-866G 4 A common gene variant and markers of body mass and fasting plasma insulin. Diabetes Obes Metab 2007; 9: 130-131.
27. Marvelle AF, Lange LA, Qin L, Adair LS, Mohlke KL. Association of FTO with obesity-related traits in the Cebu Longitudinal Health and Nutrition Survey (CLHNS) Cohort. Diabetes 2008; 57: 1987-1991.
28. Dhamrait SS, Stephens JW, Cooper JA, Acharya J, Mani AR, Moore K et al. Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. Eur Heart J 2004; 25: 468-475.
29. Ochoa MC, Santos JL, Azcona C, Moreno-Aliaga MJ, Martinez-Gonzalez MA, Martinez JA et al. Association between obesity and insulin resistance with UCP2-UCP3 gene variants in Spanish children and adolescents. Mol Genet Metab 2007; 92: 351-358.
30. Kring SI, Larsen LH, Holst C, Toubro S, Hansen T, Astrup A et al. Genotypephenotype associations in obesity dependent on definition of the obesity phenotype. Obes Facts 2008; 1: 138-145.
31. Schäuble N, Geller F, Siegfried W, Goldschmidt H, Remschmidt H, Hinney A et al. No evidence for involvement of the promoter polymorphism-866 g/a of the UCP2 gene in childhood-onset obesity in humans. Exp Clin Endocrinol Diabetes 2003; 111: 73-76.
32. Chan CB, Harper ME. Uncoupling proteins: role in insulin resistance and insulin insufficiency. Curr Diabetes Rev 2006; 2: 271-283.
33. Fisler JS, Warden CH. Uncoupling proteins, dietary fat and the metabolic syndrome. Nutr Metab 2006; 3: 38.
34. Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes. Mol Genet Metab 2004; 82: 339-344.
35. Krempler F, Esterbauer H, Weitgasser R, Ebenbichler C, Patsch JR, Miller K et al. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 2002; 51: 3331-3335.
36. Gable DR, Stephens JW, Cooper JA, Miller GJ, Humphries SE. Variation in the UCP2-UCP3 gene cluster predicts the development of type 2 diabetes in healthy middle-aged men. Diabetes 2006; 55: 1504-1511.
37. Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjogren M, Saloranta C et al. Genetic prediction of future type 2 diabetes. PLoS Med 2005; 2: e345.
38. Rai E, Sharma S, Koul A, Bhat AK, Bhanwer AJ, Bamezai RN. Interaction between the UCP2-866G/A, mtDNA 10398G/A and PGC1alpha p.Thr394Thr and p.Gly482-Ser polymorphisms in type 2 diabetes susceptibility in North Indian population. Hum Genet 2007; 122: 535-540.
39. Zee RY, Ridker PM, Chasman DI. Mitochondrial uncoupling protein gene cluster variation (UCP2-UCP3) and the risk of incident type 2 diabetes mellitus: the Women's Genome Health Study. Atherosclerosis 2011; 214: 107-109.
40. Xu K, Zhang M, Cui D, Fu Y, Qian L, Gu R et al. UCP2-866G/A and Ala55Val, and UCP3-55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study. Diabetologia 2011; 54: 2315-2324.
41. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 2003; 10: 377-386.
42. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000; 24 (Suppl 3): S6-11.
43. Andreasen CH, Mogensen MS, Borch-Johnsen K, Sandbaek A, Lauritzen T, Almind K et al. Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits. BMC Med Genet 2008; 9: 118.
44. Sparso T, Andersen G, Nielsen T, Burgdorf KS, Gjesing AP, Nielsen AL et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetolog 2008; 51: 70-75.
45. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K et al. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 1996; 98: 1195-1209.
46. WHO Study Group. Report of a WHO Consultation: Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organisation: Geneva, 1999. Ref Type: Generic.
47. Hansen T, Drivsholm T, Urhammer SA, Palacios RT, Volund A, Borch-Johnsen K et al. The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care 2007; 30: 257-262.
48. Andersen G, Overgaard J, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T et al. Studies of the association of the GNB3 825C4T polymorphism with components of the metabolic syndrome in white Danes. Diabetologia 2006; 49: 75-82.
49. Northridge ME. Public health methods-attributable risk as a link between causality and public health action. Am J Public Health 1995; 85: 1202-1204.
50. Heidari J, Akrami SM, Heshmat R, Amiri P, Fakhrzadeh H, Pajouhi M. Association study of the-866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study. Arch Iran Med 2010; 13: 384-390.
51. Srivastava N, Prakash J, Lakhan R, Agarwal CG, Pant DC, Mittal B. A common polymorphism in the promoter of UCP2 is associated with obesity and hyperinsulenemia in northern Indians. Mol Cell Biochem 2010; 337: 293-298.
52. Sandholt CH, Sparso T, Grarup N, Albrechtsen A, Almind K, Hansen L et al. Combined analyses of 20 common obesity susceptibility variants. Diabetes 2010; 59: 1667-1673.
53. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-948.
54. Brand MD, Esteves TC. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2005; 2: 85-93.
55. O'Rahilly S. Uncoupling protein 2: adiposity angel and diabetes devil? Nat Med 2001; 7: 770-772.
56. Hsu YH, Niu T, Song Y, Tinker L, Kuller LH, Liu S. Genetic variants in the UCP2-UCP3 gene cluster and risk of diabetes in the Women's Health Initiative Observational Study. Diabetes 2008; 57: 1101-1107.
57. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-678.
58. Pinelli M, Giacchetti M, Acquaviva F, Cocozza S, Donnarumma G, Lapice E et al. Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus. BMC Med Genet 2006; 7: 85.
59. Beitelshees AL, Finck BN, Leone TC, Cresci S, Wu J, Province MA et al. Interaction between the UCP2-866 G4A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes. Pharmacogenet Genomics 2010; 20: 231-238.
60. Pinkney JH, Boss O, Bray GA, Bulmer K, Coppack SW, Mohamed-Ali V. Physiological relationships of uncoupling protein-2 gene expression in human adipose tissue in vivo. J Clin Endocrinol Metab 2000; 85: 2312-2317.